Can you discuss the safety profile of liraglutide based on the results of the LEADER trial, with a specific focus on pancreatitis and pancreatic cancer?

Can you discuss the safety profile of liraglutide based on the results of the LEADER trial, with a specific focus on pancreatitis and pancreatic cancer?

Can you discuss the safety profile of liraglutide based on the results of the LEADER trial, with a specific focus on pancreatitis and pancreatic cancer?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Itamar Raz, MD

Itamar Raz, MD

Professor of Internal Medicine
Head of the Diabetes Unit
Hadassah University Hospital
Jerusalem, Israel